JPRN-UMIN000029030尚未招募未知
Adalimumab multicenter cohort study of the effectiveness for patients with Ulcerative colitis - ADVENTURE study
Sapporokosei general hospital0 个研究点目标入组 100 人开始时间: 2017年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) 2)Parial Mayo score 2 or less at baseline. 3)Not conforming to the packege insert of adalimumab until 4 weeks. 4)Patients who underwent colectomy. 5)The patints who treated with anti-TNF antibody excepted Infliximab.
研究者
相似试验
未知
3 期
A Multi-Center, Open-Labeled Study of Adalimumab in Japanese Subjects with Active Ankylosing SpondylitisAnkylosing SpondylitisJPRN-jRCT2080220558Abbott Japan Co., Ltd.30
已完成
3 期
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug TherapyArthritisPsoriaticNCT00646178Abbott102
未知
3 期
Safety, Efficacy and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid ArthritisJPRN-jRCT2080220565Abbott Japan Co., Ltd.25
已完成
3 期
Efficacy and Safety of Adalimumab in Patients With Active UveitisUveitisNCT01138657AbbVie (prior sponsor, Abbott)239
已完成
3 期
Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's DiseaseCrohn's DiseaseNCT00077779Abbott854